WALTHAM, Mass., May 10, 2017 -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that it will host an Analyst Day for the investment community on Wednesday, May 24, 2017 from 8:30 a.m. to 12:00 p.m. Eastern Time. Members of AMAG’s management team and industry experts will provide updates on the Company’s pipeline and commercial programs. In-person attendance requires advanced registration. Please email [email protected] for further information.
A live webcast of the event will be accessible through the Investors section of the company’s website at www.amagpharma.com. A replay of the webcast will also be available and archived on the site.
About AMAG
AMAG is a biopharmaceutical company focused on developing and delivering important therapeutics, conducting clinical research in areas of unmet need and creating education and support programs for the patients and families we serve. Our currently marketed products support the health of patients in the areas of maternal and women's health, anemia management and cancer supportive care. Through CBR®, we also help families to preserve newborn stem cells, which are used today in transplant medicine for certain cancers and blood, immune and metabolic disorders, and have the potential to play a valuable role in the ongoing development of regenerative medicine. For additional company information, please visit www.amagpharma.com.
AMAG Pharmaceuticals® is a registered trademark of AMAG Pharmaceuticals, Inc. and CBR® is a registered trademark of CBR Systems, Inc.
AMAG Pharmaceuticals Contact: Christi Waarich Associate Director, Investor Relations 617-498-7638


Elon Musk Shares Bold Vision for AI, Robots, and Space at Davos
SoftBank Shares Surge as AI Optimism Lifts Asian Tech Stocks
Baidu Shares Surge After Official Launch of Advanced Ernie 5.0 AI Model
Intel Stock Slides Despite Earnings Beat as Weak Q1 Outlook Raises Concerns
JPMorgan and Allen & Company Emerge as Big Winners in Warner Bros Discovery Bidding War
Tesla Plans FSD Subscription Price Hikes as Autonomous Capabilities Advance
SEC Drops Gemini Enforcement Case After Full Repayment to Earn Investors
Walmart to Cut PhonePe Stake in IPO as Tiger Global and Microsoft Exit
Apple China Holiday Sale Offers Discounts Up to 1,000 Yuan on Popular Devices
Valero Makes First Venezuelan Crude Purchase Under New U.S.-Caracas Deal
FSU Criticizes ANZ Over Suncorp Bank Job Cuts Amid Post-Acquisition Commitments
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Toyota Recalls 162,000 Tundra Vehicles in U.S. Over Multimedia Display Issue
BitGo IPO Prices Above Range, Raises $212.8M in Landmark Crypto Market Debut
Morgan Stanley Flags High Volatility Ahead for Tesla Stock on Robotaxi and AI Updates
Memory Chip Shortage Drives Higher Gadget Prices and Weakens Global Tech Demand
Nintendo Stock Jumps as Switch 2 Becomes Best-Selling Console in the U.S. in 2025 



